The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Impact BioMedical Inc shares valued at $63,476 were sold by DSS, INC. on May 22 ’25. At $0.55 per share, DSS, INC. sold 115,600 shares. The insider’s holdings dropped to 45,400 shares worth approximately $43584.0 following the completion of this transaction.
Also, DSS, INC. sold 45,400 shares, netting a total of over 24,530 in proceeds. Following the sale of shares at $0.54 each, the insider now holds 0 shares.
Before that, DSS, INC. had sold 890,800 shares from its account. In a trade valued at $845,013, the 10% Owner traded Impact BioMedical Inc shares for $0.95 each. Upon closing the transaction, the insider’s holdings decreased to 890,800 shares, worth approximately $0.15 million.
Analyzing IBO Stock Performance
On last trading session,, Impact BioMedical Inc [AMEX: IBO] rose 14.50% to $0.96. The stock’s lowest price that day was $0.9211, but it reached a high of $1.09 in the same session. During the last five days, there has been a surge of approximately 113.73%.
Support And Resistance Levels for Impact BioMedical Inc (IBO)
According to the 24-hour chart, there is a support level at 0.8919, which, if violated, would cause prices to drop to 0.8219. In the upper region, resistance lies at 1.0609. The next price resistance is at 1.1599. RSI (Relative Strength Index) is 57.62 on the 14-day chart, showing neutral technical sentiment.
Is Impact BioMedical Inc subject to short interest?
Stocks of Impact BioMedical Inc saw a sharp rise in short interest on 2025-05-30 jumping by 63738.0 shares to 0.35 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 0.28 million shares. A jump of 18.38% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 0.04 of the overall float, the days-to-cover ratio (short ratio) jumped to 0.04.
